Exhibit 23.1
30 Old Bailey London EC4M 7AU United Kingdom
Tel: +44 (0)20 7063 4000
www.mazars.co.uk |
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Biodexa Pharmaceuticals PLC
Caspian Point
Caspian Way
Cardiff
CF10 4DQ
United Kingdom
The Board of Directors of Biodexa Pharmaceuticals PLC
We consent to the inclusion of our audit report dated April 18, 2024, which is incorporated in the Registration Statements on Form F-1 (No. 333-278040), on the consolidated statement of financial position of Biodexa Pharmaceuticals PLC (the “Company”) and its subsidiaries as of December 31, 2023, 2022 and 2021 and the related consolidated statements of comprehensive income, cash flow, changes in equity for each of the three years in the period ended December 31, 2023, and the related notes which appear in the Form 20-F filed on April 18th, 2024. Our report contains an explanatory paragraph about the existence of substantial doubt concerning Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Registration Statement.
/s/ Mazars LLP
Mazars LLP
London, United Kingdom
April 29th, 2024
Mazars LLP
Mazars LLP is the UK firm of Mazars, an integrated international advisory and accountancy organisation. Mazars LLP is a limited liability partnership registered in England and Wales with registered number OC308299 and with its registered office at 30 Old Bailey, London, EC4M 7AU. Registered to carry on audit work in the UK by the Institute of Chartered Accountants in England and Wales. Details about our audit registration can be viewed at www.auditregister.org.uk under reference number C001139861. VAT number: GB 839 8356 73